Baby Meera of Mrs. Kavita, a 3 day old (54 hours) term female newborn, second living child of non-consanguineous marriage from Paschim Vihar, New Delhi, presented with complaints of yellowish discoloration of skin and eyes since 28 hours of life and increasing lethargy with poor feeding since 40 hours of life.

HOPI

• The infant was born at term with uneventful immediate birth history and was discharged home on direct breastfeeding at 24 hours of life. Jaundice was first noticed at 28 hours. Since the onset is within the first week of life with rapid progression, I would like to start the history from antenatal period with special emphasis on maternal blood group and isoimmunization status.

• Antenatal
  • The mother was 30 years of age at the time of conception. $G_3 P_2 A_1 L_1$
  • Non-consanguineous marriage. Registered at 8 weeks. Folic acid taken regularly
  • No history of fever with rash or exanthem in any trimester
  • Anomaly scan normal. Received 2 doses of Td vaccine
  • MCA-PSV Doppler at 24 weeks was < 1.5 MoM (no severe fetal anemia at that time) (MCA-PSV > 1.5 MoM suggests severe fetal anemia requiring intrauterine transfusion)
  • Serial MCA-PSV Dopplers at 32 and 36 weeks showed mild elevation (1.35 MoM). No hydrops fetalis on USG
  • Maternal blood group: A Negative (Rh-D Negative). Paternal blood group: A Positive (Rh-D Positive — homozygous D)
  • Indirect Coombs Test (ICT) at 32 weeks gestation — Positive (1:64), indicating active Rh-D maternal isoimmunization (rising titre indicates active sensitization; titre > 1:16 is significant)
  • Anti-D immunoglobulin was NOT administered during 28th week of gestation (Anti-D 300 μg should be given at 28 weeks and within 72 hours postpartum to prevent sensitization)
  • Obstetric history:
    • $G_1$ (2022): Spontaneous abortion at 10 weeks. Anti-D Ig was NOT administered post-curettage
    • $G_2$ (2024): Full-term male child, delivered at home, developed severe jaundice on day 2, required ICU admission and phototherapy. Child currently has mild motor delay (previous affected sibling strongly suggests Rh isoimmunization)
• Natal history
  • Delivered at 38+4 weeks by spontaneous vaginal delivery. Clear amniotic fluid. Birth weight 2850 g (AGA)
  • The child cried immediately after birth. Apgar 8/10 at 1 minute and 9/10 at 5 minutes
  • Delayed cord clamping was avoided — cord clamped at 15 seconds due to known maternal Rh isoimmunization (to prevent excessive placental auto-transfusion of maternal antibodies)
  • Discharged home on direct breastfeeding at 24 hours of life
• Postnatal course
  • Jaundice first noticed at 28 hours of life as yellowish tinge over face and sclera (onset < 24–36 hours is pathological — suggests hemolytic disease)
  • Rapidly progressive over next 12–15 hours. By 36 hours, icterus extended to abdomen, thighs, palms, and soles (Kramer Zone 5) (Zone 5 positive — estimated TSB ≥ 15–18 mg/dL)
  • Cephalocaudal progression: face → trunk → abdomen → lower limbs → palms and soles
  • Since 40 hours of life — progressively somnolent, difficult to rouse for feeds, weak high-pitched cry (early signs of acute bilirubin encephalopathy)
  • Direct breastfeeding attempted every 2–3 hours but suck duration decreased to < 5 minutes per feed due to lethargy
  • Passed dark green meconium at 12 hours. Currently passing normal transitional yellowish-green stools (not pale/acholic)
  • Urine passed 5 times in last 24 hours — light yellow, no dark staining on diaper (acholic stools or dark urine staining suggests conjugated hyperbilirubinemia)
  • Admitted to NICU at 33 hours of life for management of hyperbilirubinemia
• No history of seizures, opisthotonus, or retrocollis (advanced ABE phase 2/3)
• No history of cephalhematoma, subgaleal hemorrhage, or extensive bruising (rules out extravascular blood breakdown)
• No history of maternal intake of oxidant drugs, sulfonamides, or antimalarials (rules out drug-induced hemolysis or G6PD trigger)
• No family history of G6PD deficiency, hereditary spherocytosis, or early splenectomy (rules out inherited RBC defects)
• No history of pale clay-colored stools (rules out biliary atresia / conjugated hyperbilirubinemia)
• No history of hypothermia, chest retractions, abdominal distension, or umbilical discharge (rules out neonatal sepsis with DIC)
• No history of prolonged constipation, umbilical hernia, or macroglossia (rules out congenital hypothyroidism)
• No history of bilious vomiting (rules out galactosemia / intestinal obstruction)

Past History

• Previous sibling ($G_2$) had severe neonatal jaundice requiring ICU admission and phototherapy — currently has mild motor delay
• No other hospital admissions for index case except current NICU admission since 33 hours of life
• No history of any drug intake or drug allergies

Family history

• $G_3 P_2 A_1 L_1$. Second living child born of non-consanguineous marriage
• Mother A Negative (Rh-D Negative). Father A Positive (Rh-D Positive)
• Previous male sibling affected with severe neonatal jaundice with residual motor delay — likely kernicterus sequelae
• No family history of G6PD deficiency, hereditary spherocytosis, or metabolic diseases

% Meera — Rh isoimmunization (Neonatal Jaundice)
I1 F UAf [label:Mother|A Negative]
I2 M UAf [label:Father|A Positive]
II1 M Af [label:Brother|Jaundice|Motor delay]
II2 F Af 54h index [label:Meera|Rh HDN]

~ I1-I2 > II1,II2

Immunization history

• Birth dose vaccines given before discharge at 24 hours
• BCG 0.05 mL intradermal — given
• Hepatitis B birth dose 0.5 mL IM — given
• Zero-dose bOPV 2 drops oral — given
• Vitamin K1 1.0 mg IM — given at birth

Dietary history

Parameter	Observed	Expected	Inference
Mode of feeding	Direct breastfeeding attempted	EBF on demand	Poor intake due to lethargy
Suck duration	< 5 min per feed (decreased)	15–20 min	Inadequate — secondary to ABE
Feeds per 24 hours	Every 2–3 hours attempted	8–12	Attempted but poor efficiency
Pre-lacteal feeds	None	None	Adequate
Stool	Transitional yellowish-green	Yellow transitional	Not acholic — rules out cholestasis
Urine output	5 times/24 hours	≥ 6 after day 3	Mildly reduced

• Breastfeeding attempted but poor suck due to lethargy and somnolence
• Expressed breast milk via cup/paladai started after NICU admission
• No food allergies

Socioeconomic and KAP

• The family lives in a pucca house in Paschim Vihar, New Delhi
• Water supply from municipal corporation. Lower middle socioeconomic status
• Parents were not aware of the importance of Anti-D immunoglobulin during previous pregnancies. Now understand the diagnosis and willing to comply with NICU treatment

Summary of History

Meera, baby girl of Mrs. Kavita, is a 54 hour old term female newborn born at 38+4 weeks (AGA, 2850 g) to an A Negative Rh-D sensitized mother (ICT 1:64, no antenatal Anti-D given) with a previous affected sibling. She developed rapidly progressive unconjugated hyperbilirubinemia at 28 hours of life with cephalocaudal spread to palms and soles, associated lethargy, weak suck, and high-pitched cry suggestive of early acute bilirubin encephalopathy.

I would like to think of isoimmune hemolytic disease of the newborn due to Rh-D isoimmunization (maternal A Negative, expected child Rh-D Positive), presenting with severe unconjugated hyperbilirubinemia and early acute bilirubin encephalopathy (BIND score 3), without features of conjugated cholestasis or neonatal sepsis.

General head to toe examination

• The neonate was examined in the NICU under phototherapy unit, rousable but somnolent
• Vitals
  • Temperature - 36.7°C — afebrile
  • PR - 148/min, regular, good peripheral pulses
  • RR - 46/min, regular, no retractions or grunting
  • CRT - < 2 seconds
  • SpO2 - 98% on room air
• Anthropometry

Parameter	Observed	Centile (WHO)	Inference
Weight	2710 g	50th	AGA; weight loss 4.9%
Length	49.0 cm	50th	Normal term length
HC	34.0 cm	50th	Normocephalic

• Head to toe Examination
  • Marked generalized icterus extending to palms and soles. Mild pallor present
  • No dysmorphic features
  • Eyes — scleral icterus bilaterally, no purulent discharge
  • Skin — icteric in all Kramer zones (Zone 5 positive). No petechiae, purpura, or ecchymosis
  • No cephalhematoma, subgaleal hematoma, caput, or bruising
  • Abdomen — liver palpable 2.5 cm below right costal margin, firm (hepatomegaly). Spleen palpable 1.5 cm below left costal margin (splenomegaly) (hepatosplenomegaly suggests active hemolysis with extramedullary hematopoiesis)
  • Umbilical cord stump clean, no omphalitis
  • Female genitalia — normal. Anus patent
  • No limb defects or neurocutaneous markers

Systemic Examination

CNS

• HMF
  • Somnolent but rousable to stimulation
  • Weak high-pitched cry when stimulated
  • Poor feeding — weak suck, easily fatigued
• BIND Score (Bilirubin-Induced Neurological Dysfunction)

Parameter	Finding	Score
Mental status	Somnolent, lethargic, reduced response to stimulation	1
Muscle tone	Mild hypotonia, subtle decrease in flexor tone	1
Cry characteristics	High-pitched cry when stimulated, short duration	1
Total BIND Score		3 / 9

• Interpretation: Mild / early acute bilirubin encephalopathy (ABE Stage 1) (BIND ≥ 3 with TSB > exchange threshold — prepare for DVET)
• Primitive Reflexes
  • Moro — incomplete/sluggish extension and abduction
  • Sucking — weak and easily fatigued
  • Palmar grasp — present bilaterally
  • Plantar grasp — present bilaterally
• No opisthotonus, retrocollis, or seizure activity

Jaundice Assessment

• Kramer cephalocaudal dermal zones

Zone	Area	Status
Zone 1	Head and neck	Icteric
Zone 2	Upper trunk to umbilicus	Icteric
Zone 3	Lower abdomen to midthighs	Icteric
Zone 4	Forearms, wrists, lower legs	Icteric
Zone 5	Palms and soles	Icteric (positive)

• Clinical estimate by Kramer's rule: TSB ≥ 15–18 mg/dL

other systems

• Respiratory system — b/l air entry +, NVBS, no added sounds, no retractions — NAD
• Cardiovascular — s1s2 heard, no murmur, good peripheral pulses — NAD
• abdominal — soft, hepatosplenomegaly as described above, bowel sounds heard

Summary

A 54 hour old term female second living child of non-consanguineous parents (mother A Negative Rh-D sensitized, ICT 1:64, no Anti-D given), presented with rapidly progressive jaundice since 28 hours of life with cephalocaudal spread to Zone 5 (palms and soles), lethargy, poor feeding, and high-pitched cry. Examination revealed marked icterus, mild pallor, hepatosplenomegaly (liver 2.5 cm, spleen 1.5 cm), and BIND score 3 indicating early acute bilirubin encephalopathy, without features of conjugated cholestasis or sepsis.

The probable diagnosis is isoimmune hemolytic disease of the newborn due to Rh-D isoimmunization with severe unconjugated hyperbilirubinemia (TSB 21.4 mg/dL) and early acute bilirubin encephalopathy (ABE Stage 1), complicated by moderate hemolytic anemia (Hb 11.2 g/dL).

Differential Diagnosis

Condition	Points IN FAVOR	Points AGAINST
Rh Isoimmunization (HDN)	Onset < 36 h, maternal A Negative/ICT positive, hepatosplenomegaly, rapid progression, pallor, previous affected sibling, early lethargy	Primary Diagnosis
ABO Incompatibility	Early onset jaundice, DCT can be positive	Mother is A Negative (ABO mismatch typically requires mother O, child A or B)
G6PD Deficiency	Rapid bilirubin rise, acute hemolysis	No family history or oxidant trigger; less prominent hepatosplenomegaly
Neonatal Sepsis with Hemolysis	Lethargy, poor feeding, icterus	Afebrile, normal CRT, clean cord, no PROM or maternal fever
Breastfeeding Jaundice	Poor feeding, weight loss	Onset usually days 3–5; does not explain onset < 28 h, pallor, or hepatosplenomegaly
Physiological Jaundice	Day 3 of life	Onset at 28 hours with Zone 5, pallor, and hemolysis markers — pathological

Investigation Protocol & Diagnostic Workup

flowchart TD
    A["Neonate with Jaundice<br/>Assess Onset & Kramer Zone"] --> B{Onset < 24–36 hours<br/>or Zone 4–5?}
    B -->|Yes - Pathological| C["Maternal & Infant<br/>Blood Group + Rh"]
    B -->|No - Physiological| D["Plot TSB on<br/>Bhutani Nomogram"]
    C --> E["Direct Coombs Test<br/>(DCT)"]
    E --> F{DCT Result?}
    F -->|Positive| G["Isoimmune HDN<br/>Rh / ABO / Minor Antigen"]
    F -->|Negative| H["Check G6PD<br/>PBS / Reticulocyte Count"]
    G --> I["TSB + Direct Bilirubin<br/>Hemoglobin / Hematocrit<br/>Reticulocyte Count / PBS"]
    H --> I
    I --> J["Calculate B/A Ratio<br/>Bilirubin ÷ Albumin"]
    J --> K{BIND Score &<br/>AAP Threshold?}
    K -->|Below phototherapy line| L["Observation + Follow-up"]
    K -->|Above phototherapy line| M["Intensive Phototherapy<br/>+ IV Fluids"]
    K -->|Above exchange line<br/>or BIND ≥ 3| N["IVIG 0.5–1 g/kg<br/>Prepare for DVET"]
    N --> O["Double Volume Exchange<br/>Transfusion if no response"]
    D --> P["Discharge when<br/>TSB declining & feeding well"]

1. Key Laboratory Results

Investigation	Observed	Normal Reference	Interpretation
Total Serum Bilirubin (TSB)	21.4 mg/dL	< 12.0 mg/dL at 54 h	Exceeds exchange transfusion cutoff
Direct (conjugated) bilirubin	0.8 mg/dL	< 1.0 mg/dL	Pure unconjugated hyperbilirubinemia
Indirect bilirubin	20.6 mg/dL	—	High neurotoxic unconjugated fraction
Infant blood group & Rh	O Positive (Rh-D Positive)	—	Rh mismatch confirmed (mother A− / child O+)
Direct Coombs Test (DCT)	Strongly positive (3+)	Negative	Confirms isoimmune hemolysis
Hemoglobin / Hematocrit	11.2 g/dL / 34%	14.5–18.5 g/dL	Moderate hemolytic anemia
Reticulocyte count	11.8%	2.0–6.0%	Marked compensatory erythropoiesis
Peripheral blood smear	Polychromasia, nRBCs 22/100 WBCs, microspherocytes	Rare nRBCs	Active Rh hemolytic process
Serum albumin	3.1 g/dL	> 3.5 g/dL	B/A ratio elevated

$$ \text{Bilirubin / Albumin (B/A) Ratio} = \frac{21.4}{3.1} = 6.9\text{ mg/g} $$

B/A ratio > 6.8 at 54 hours indicates high risk of free bilirubin penetration into the CNS

2. Additional Workup

• Maternal ICT (Indirect Coombs): Positive 1:64 at 32 weeks — confirms sensitization
• Antibody identification: Anti-D confirmed on maternal serum
• TSB monitoring: Every 4 hours during intensive phototherapy — target drop 1–2 mg/dL in 4–6 hours

3. Neurodevelopmental Baseline

• BIND score: 3/9 — document for long-term follow-up
• Amplitude-integrated EEG (aEEG): If available, to detect subclinical seizures
• Brainstem auditory evoked response (BAER): Before discharge and at 3 months (risk of auditory neuropathy)

Management Plan

1. Intensive Phototherapy

• LED phototherapy: Wavelength 460–490 nm, irradiance > 30 μW/cm²/nm, placed 20–30 cm above infant
• Double-surface phototherapy: Above and below with maximum skin exposure (eye patch and diaper only)
• Hydration: Continue enteral feeds (expressed breast milk via cup/paladai); add 15–20% extra IV fluids to compensate for insensible water loss under phototherapy
• Monitor TSB: Every 4 hours — target > 1–2 mg/dL drop in 4–6 hours

2. Intravenous Immunoglobulin (IVIG)

• Indication: Isoimmune hemolytic disease with TSB approaching or exceeding exchange transfusion levels despite intensive phototherapy
• Dose: 0.5–1.0 g/kg IV infusion over 2 hours; repeat in 12 hours if TSB remains high
• Mechanism: Blocks Fc receptors on macrophages, slowing antibody-mediated RBC destruction

3. Double Volume Exchange Transfusion (DVET)

• Indication: TSB 21.4 mg/dL at 54 hours exceeds AAP 2022 exchange transfusion line (19.0 mg/dL for term with neurotoxicity risk factors) + BIND score 3
• Blood specification:
  • RBC component: O Negative (compatible with maternal anti-D antibodies)
  • Plasma component: AB Positive (or child-compatible plasma)
  • Reconstituted hematocrit: 45–50%
  • Crossmatch: Against maternal serum
• Volume: $2 \times 85 \text{ mL/kg} \times 2.7 \text{ kg} \approx 460 \text{ mL}$
• Technique: Push-pull via umbilical venous catheter, aliquots of 10–15 mL over 1.5–2 hours
• Calcium gluconate: 1 mL of 10% IV after every 100 mL exchanged to prevent citrate-induced hypocalcemia

4. Supportive Care

• Maintain thermo-neutral environment: Monitor temperature during phototherapy
• Nutrition: Expressed breast milk via cup/paladai; do not withhold feeds during phototherapy
• Monitor for complications: Hypocalcemia, dehydration, bronze baby syndrome, circadian rhythm disruption

5. Maternal Counseling & Future Pregnancy Planning

• Anti-D immunoglobulin: 300 μg within 72 hours postpartum (mandatory)
• Future pregnancies: Anti-D at 28 weeks + within 72 hours post-delivery; close antenatal monitoring with serial ICT and MCA-PSV Doppler
• Fetal medicine referral: For intrauterine transfusion if MCA-PSV > 1.5 MoM in future pregnancies

6. Long-Term Follow-Up

• Neurodevelopmental assessment: At 3, 6, 12 months and annually (risk of kernicterus sequelae — choreoathetoid CP, sensorineural hearing loss, upward gaze palsy)
• Hearing screening: BAER at discharge and 3 months
• Hemoglobin monitoring: Weekly until reticulocytosis resolves

---

Related

• Topic Hub
• Case Proforma
• Viva Questions